Full-Time
Fund Management Analyst
Confirmed live in the last 24 hours
MicroVentures
51-200 employees
Equity crowdfunding platform for investors
No salary listed
Junior
Austin, TX, USA
This position is hybrid, requiring some in-office days.
- Bachelor’s degree in accounting, finance, or economics
- At least one year of work experience, preferably within the financial industry
- Strong organizational and documentation skills
- Strong verbal and written communication skills
- Keen eye for details to identify trends, cause and effects
- Ability to manage multiple tasks and priorities at once
- Strategic thinker focused on continuous improvement
- Professional demeanor and strong work ethic
- Proficiency with Office Suite, especially Excel (formulas, macros, pivot tables, etc.)
- Assist in the establishment and maintenance of over 800 Venture Funds
- Prepare investor notices, including capital call, fee, and distribution notices
- Process outgoing and incoming payments
- Maintain key databases to fulfill ad-hoc requests for Fund and investor data
- Participate on special projects related to the fund
- Assist in the preparation of applicable tax forms (e.g., Form 1065)
- Ensure compliance with regulatory requirements and other requirements of the funds’ specifications
- Collaborate with compliance, operations, and executive leadership teams to meet all requirements to the highest standards of quality
MicroVentures operates an equity crowdfunding platform that allows both accredited and non-accredited investors to invest in high-growth startups and private market opportunities. The platform simplifies the investment process by providing access to early-stage investments that were once limited to venture capitalists and institutional investors. MicroVentures generates revenue through a dual-fee structure, where investors pay a fee based on their investment amount, and companies pay a fee to list their fundraising campaigns. Additionally, the company offers educational resources to help investors understand the risks and make informed decisions about equity crowdfunding. This focus on accessibility and education sets MicroVentures apart from its competitors in the fintech market.
Company Size
51-200
Company Stage
N/A
Total Funding
$3.2M
Headquarters
Austin, Texas
Founded
2009
Simplify's Take
What believers are saying
- Growing interest in equity crowdfunding supports MicroVentures' business model.
- Increased demand for community-driven investment platforms aligns with MicroVentures' offerings.
- Biotechnology sector's growth presents opportunities for MicroVentures to support medical research.
What critics are saying
- Rising competition from new crowdfunding platforms like Anfin.
- Potential market saturation in the equity crowdfunding space.
- Regulatory scrutiny in the fintech sector could impact MicroVentures.
What makes MicroVentures unique
- MicroVentures connects both accredited and non-accredited investors with startups.
- The platform offers early-stage investment opportunities traditionally limited to venture capitalists.
- MicroVentures uses a dual-fee structure, earning from both investors and companies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Company Equity
Performance Bonus
Company News
Oakland-based Mighty Buildings, which is on a quest to build homes using 3D printing, robotics and automation, has raised a $22 million extension to its Series B round of funding. The company claims to be able to 3D print structures “two times as quickly with 95% less labor hours and 10-times less waste” than conventional construction. For example, it says it can 3D print a 350-square-foot studio apartment in just 24 hours.
3D Printed Biodegradable Mesh Designed to Deliver Cancer Drugs Directly to Tumor Site With Greater Efficacy, Reduced Side Effects
ICON, in one of the largest seed rounds for Texas start-ups in 2018, announces $9M in funding.
Rochester, MN | February 10, 2023 – Pneumeric Inc., developers of the Capnospot™ - A disposable medical device that allows visual detection of carbon dioxide during treatment of a collapsed lung with needle decompression, has raised nearly $40,000 from 124 investors through its recently launched equity crowdfunding campaign. These funds build on the $1.2 million Pneumeric has
BOSTON, Aug. 15, 2022 /PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has closed more than $2.3M in its expanded seed round financing. Funding from the raise is being used to study Remedium's lead product, a single-injection gene therapy potentially capable of reversing cartilage loss, in a collaboration with Tufts University School of Medicine scientists researching rheumatic disorders. The financing was led by Sherwood Ventures and included participation from, LongevityTech.Fund, Primo Medical Group, Angel Star Ventures, Apis Health Angels, MicroVentures, and Guindy Alumni Angels. Potential to reverse years of age-related cartilage loss Tweet this We believe that any disease can be cured. - Remedium Bio